61-75 of 97

Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®Remnant Cholesterol: The Missing Link in ASCVD risk

SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®SHTG: Decoding the Latest Clinical Trial Outcomes

Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®Effective Monitoring and Management of Adverse Effects in Metastatic ESCC

Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
MinuteCE®Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
MinuteCE®Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
- advertisement

The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
MinuteCE®The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
MinuteCE®ICI Combination Regimens for First-Line Treatment of Metastatic ESCC

The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC

Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
MinuteCE®Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC

Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
CME/CEChairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
- advertisement

Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
CME/CEAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective

The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective
CME/CEThe Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Broadcast ReplayAdvances in the Treatment and Management of MASH: More Options, More Decisions
































